secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROKIDNEY CORP. (PROK)
CIK:        0001850270
Form:       8-K
Filed at:   2024-03-25T23:59:59+00:00
Accession:  0000950170-24-035914
Event type: leadership
Sentiment:  positive
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ProKidney appoints EVP Technical Operations and SVP Global Clinical Operations
------------------------------------------------------------------------------

- Ulrich Ernst appointed EVP Technical Operations; base salary $450,000, target bonus 40%.
- Ernst receives option for 500,000 Class A shares; 335,000 time-vesting, 165,000 performance-vesting.
- Lucio Tozzi appointed SVP Global Clinical Operations on Jan 22, 2024; over 30 years experience.
- Both executives join Leadership Team to support Phase 3 program and BLA preparation.
- Ernst previously SVP at Iovance Biotherapeutics; Tozzi held senior roles at Summit Therapeutics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850270/000095017024035914/0000950170-24-035914-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850270/000095017024035914/prok-20240325.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-035914

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer